Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vishal Bhatnagar

Showing results (11-20 of 75) with videos related to

Pageof 8
Sort By:
Cancer|October 22, 2025
Assessing tolerability of cancer therapeutics: A regulatory perspective from the FDA Oncology Center of ExcellenceVishal Bhatnagar, Laura Lee Johnson, Mallorie H Fiero, et al.
Heliyon|February 7, 2024
LSTMCNN: A hybrid machine learning model to unmask fake newsDeepali Goyal Dev, Vishal Bhatnagar, Bhoopesh Singh Bhati, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 1, 2020
The Evolution of Clinical Trials in Metastatic Breast Cancer: Design Features and Endpoints That MatterAndrew D Seidman, Julia Maues, Tiah Tomlin, et al.
Indian Journal of Anaesthesia|July 12, 2021
Utility of lung ultrasound for extravascular lung water volume estimation during cytoreductive surgery and hyperthermic intraperitoneal chemotherapyAmit Kumar Mittal, Jiten Jaipuria, Anil Patel, et al.
Cureus|August 4, 2023
Comparative Study Between Intravenous Patient-Controlled Analgesia Morphine and Computerized Ambulatory Delivery Device Epidural Morphine for Post Operative Analgesia for Nuss Procedure in Pectus Excavatum: A Retrospective AnalysisVishal Bhatnagar, Ravi Kumar, Anshu Singh, et al.
Clinical Trials (London, England)|May 16, 2022
Timing is everything: The importance of patient-reported outcome assessment frequency when characterizing symptomatic adverse eventsBellinda L King-Kallimanis, Vishal Bhatnagar, Erica G Horodniceanu, et al.
Pharmacoepidemiology and Drug Safety|August 15, 2019
Analyzing patient-reported outcome data when completion differs between arms in open-label trials: an application of principal stratificationJessica K Roydhouse, Roee Gutman, Vishal Bhatnagar, et al.
Blood Cancer Journal|September 1, 2021
Review of patient-reported outcomes in multiple myeloma registrational trials: highlighting areas for improvementLaura L Fernandes, Jiaxi Zhou, Bindu Kanapuru, et al.
Archives of Iranian Medicine|January 6, 2015
Diseases at the crossroads: chronic myelogenous leukemia and tuberculosisVishal Bhatnagar, Akintoye Adelakun, Trisha Kendall, et al.
Journal of Patient-Reported Outcomes|November 17, 2023
Use of patient-reported outcomes (PRO) data to complement exposure-response analysis in early clinical cancer drug developmentHuiming Xia, Brian P Booth, Yaning Wang, et al.
Pageof 8

Showing results (11-20 of 75) with videos related to

Sort By:
Pageof 8
Cancer|October 22, 2025
Assessing tolerability of cancer therapeutics: A regulatory perspective from the FDA Oncology Center of ExcellenceVishal Bhatnagar, Laura Lee Johnson, Mallorie H Fiero, et al.
Heliyon|February 7, 2024
LSTMCNN: A hybrid machine learning model to unmask fake newsDeepali Goyal Dev, Vishal Bhatnagar, Bhoopesh Singh Bhati, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 1, 2020
The Evolution of Clinical Trials in Metastatic Breast Cancer: Design Features and Endpoints That MatterAndrew D Seidman, Julia Maues, Tiah Tomlin, et al.
Indian Journal of Anaesthesia|July 12, 2021
Utility of lung ultrasound for extravascular lung water volume estimation during cytoreductive surgery and hyperthermic intraperitoneal chemotherapyAmit Kumar Mittal, Jiten Jaipuria, Anil Patel, et al.
Cureus|August 4, 2023
Comparative Study Between Intravenous Patient-Controlled Analgesia Morphine and Computerized Ambulatory Delivery Device Epidural Morphine for Post Operative Analgesia for Nuss Procedure in Pectus Excavatum: A Retrospective AnalysisVishal Bhatnagar, Ravi Kumar, Anshu Singh, et al.
Clinical Trials (London, England)|May 16, 2022
Timing is everything: The importance of patient-reported outcome assessment frequency when characterizing symptomatic adverse eventsBellinda L King-Kallimanis, Vishal Bhatnagar, Erica G Horodniceanu, et al.
Pharmacoepidemiology and Drug Safety|August 15, 2019
Analyzing patient-reported outcome data when completion differs between arms in open-label trials: an application of principal stratificationJessica K Roydhouse, Roee Gutman, Vishal Bhatnagar, et al.
Blood Cancer Journal|September 1, 2021
Review of patient-reported outcomes in multiple myeloma registrational trials: highlighting areas for improvementLaura L Fernandes, Jiaxi Zhou, Bindu Kanapuru, et al.
Archives of Iranian Medicine|January 6, 2015
Diseases at the crossroads: chronic myelogenous leukemia and tuberculosisVishal Bhatnagar, Akintoye Adelakun, Trisha Kendall, et al.
Journal of Patient-Reported Outcomes|November 17, 2023
Use of patient-reported outcomes (PRO) data to complement exposure-response analysis in early clinical cancer drug developmentHuiming Xia, Brian P Booth, Yaning Wang, et al.
Pageof 8